Skip to content

The efficacy of Ceftriaxone Sulbactam versus Amoxicillin Clavulanic Acid as prophylaxis in Caesarean section

The efficacy of Ceftriaxone Sulbactam versus Amoxicillin Clavulanic Acid as prophylaxis in Caesarean section in Federal Medical Centre Abeokuta: A randomised controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202602520357441
Enrollment
140
Registered
2026-02-20
Start date
2025-05-05
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

surgical site infection post caeserean section

Interventions

ceftriaxone sulbactam

Sponsors

DANIEL OHU
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients requiring both emergency and elective caesarean sections that have been counseled on antibiotic prophylaxis and who give their consent will be selected for the study.

Exclusion criteria

Exclusion criteria: Patients with Prelabour rupture of fetal membranes of more than 12hours 2. Patients with suspected or proven Chorioamnionitis 3. Patients with prior sepsis 4. Patients with prolonged/obstructed labour 5. Patients with intrauterine fetal death 6. Patients with known allergy to the trial drugs 7. Patients who have received any antibiotics in the preceding 24 hours 8. Patients with medical conditions in pregnancy such as: hemoglobinopathies, severe pre- eclampsia or eclampsia, Human Immunodeffiency Virus/Acquired Immunodefiency Syndrome, diabetes mellitus 10. Those that had more than 6 vaginal examinations prior to surgery

Design outcomes

Primary

MeasureTime frame
surgical site infection

Secondary

MeasureTime frame
duration of hospital stay

Countries

Nigeria

Contacts

Public Contactdaniel ohu

senior registrar

danielohu@yahoo.co.uk08037181100

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Jun 29, 2026